Blue Trust Inc. Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Blue Trust Inc. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,747 shares of the medical equipment provider’s stock after acquiring an additional 1,014 shares during the quarter. Blue Trust Inc.’s holdings in Intuitive Surgical were worth $2,332,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also modified their holdings of ISRG. AQR Capital Management LLC increased its stake in Intuitive Surgical by 12.6% during the second quarter. AQR Capital Management LLC now owns 42,691 shares of the medical equipment provider’s stock worth $18,958,000 after acquiring an additional 4,775 shares during the last quarter. Creative Planning increased its position in shares of Intuitive Surgical by 9.8% during the 2nd quarter. Creative Planning now owns 63,039 shares of the medical equipment provider’s stock valued at $28,043,000 after purchasing an additional 5,629 shares during the last quarter. NewEdge Advisors LLC raised its holdings in Intuitive Surgical by 8.2% during the 2nd quarter. NewEdge Advisors LLC now owns 13,825 shares of the medical equipment provider’s stock valued at $6,150,000 after buying an additional 1,044 shares during the period. Northwestern Mutual Wealth Management Co. lifted its position in Intuitive Surgical by 2.1% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 20,458 shares of the medical equipment provider’s stock worth $9,100,000 after buying an additional 411 shares during the last quarter. Finally, Wellington Wealth Strategies LLC. purchased a new position in Intuitive Surgical during the second quarter worth $241,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $573.48 on Tuesday. The stock’s fifty day moving average price is $547.16 and its 200 day moving average price is $505.21. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a market cap of $204.26 billion, a price-to-earnings ratio of 92.20, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Insider Activity

In other news, insider Jamie Samath sold 269 shares of the business’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41. Following the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,727,816.73. The trade was a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 42,265 shares of company stock worth $21,964,281 over the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on ISRG shares. JPMorgan Chase & Co. increased their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday. Robert W. Baird raised their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday. Royal Bank of Canada raised their price target on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday. Finally, Barclays boosted their price objective on Intuitive Surgical from $610.00 to $674.00 in a report on Monday. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.